Advisor Group Holdings, Inc. Galectin Therapeutics Inc Transaction History
Advisor Group Holdings, Inc.
- $43.4 Billion
- Q1 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,264,845 shares of GALT stock, worth $2.86 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,264,845
Previous 1,251,048
1.1%
Holding current value
$2.86 Million
Previous $2.08 Million
45.57%
% of portfolio
0.01%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding GALT
# of Institutions
65Shares Held
7.62MCall Options Held
61.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.98MShares$4.47 Million0.0% of portfolio
-
Black Rock Inc. New York, NY713KShares$1.61 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA567KShares$1.28 Million0.0% of portfolio
-
Geneos Wealth Management Inc.409KShares$924,0000.05% of portfolio
-
Wealthspire Advisors, LLC New York, NY398KShares$900,3250.01% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $134M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...